United Kingdom · Question · Written question
UIN 22376
Rare Diseases: Drugs
Introduced
17 April 2024
Last action
22 April 2024 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
22 April 2024
Summary
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to support effective routes to market for precision medicines for (a) motor neurone disease and (b) other rare diseases in the UK.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
17 April 2024
Written question
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to support effective routes to market for precision medicines for (a) motor neurone disease and (b) other rare diseases in the UK.
Source: Commons
22 April 2024
Answer
Should the Medicines and Healthcare products Regulatory Agency (MHRA) receive a marketing authorisation application (MAA) or applications, the MHRA will consider the drug with regards to quality, safety, and efficacy. The MHRA has procedures in place to c...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2024-04-17/22376
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1701903
- uk · wq-1701903 · source updated 22 April 2024